Conference/Events
| ShowHide Related Items >><< - 01/15/21
- Teva ANDA for Bexarotene approved by FDA
- 01/14/21
- Teva announces availability of generic version of NuvaRing
- 01/07/21
- Teva, MedinCell present results for study on efficacy of schizophrenia treatment
- 11/27/20
- Teva receives tentative approval from FDA for micafungin sodium
- 05:33 Today
- Addex Therapeutics receives IND approval to start study in epilepsy
- 01/19/21
- Royalty Pharma acquires royalty interest in Seltorexant from Minerva
- 01/19/21
- Minerva, Royalty Pharma announce sale of seltorexant royalty for up to $155M
- 01/15/21
- Halozyme says Janssen receives FDA approval of Darzalex Faspro
- 12/20/20
- Fly Intel: Top five weekend stock stories
- 12/20/20
- FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S.
- 12/04/20
- McKesson, Amgen sign strategic agreement to help improve cancer care
- 11/19/20
- McKesson names Dr. Kevin Baggett as Chief Impact Officer
- 01/06/21
- AmerisourceBergen to acquire Alliance Healthcare from Walgreens for $6.5B
- 11/09/20
- AmerisourceBergen names Dr. Lonie Haynes as Chief Diversity & Inclusion Office
- 11/06/20
- AmerisourceBergen reaches agreement with CDC over pharmacy vaccine access
- 11/05/20
- AmerisourceBergen sees FY21 CapEx ~$400M
- 12/14/20
- Cardinal Health chosen to distribute COVID-19 vaccines in Ohio
- 12/04/20
- Jaguar Health enters fifth amendment to accounts receivable agreement with Oasis
- 11/11/20
- Cardinal Health reports CDC pact for Phase 2 of Federal Pharmacy Partnership
- 11/03/20
- McKesson says AGs seek up to $21B from pharma distributors in opioid settlement
- 01/11/21
- CVS Health names Laurie Havanec as Chief People Officer
- 01/06/21
- CVS Health names Michelle Peluso as first-ever Chief Customer Officer
- 01/06/21
- CVS Health: No COVID-19 vaccines currently available at CVS Pharmacy locations
- 01/06/21
- CVS Health administering COVID-19 vaccines in SNF's in 49 states
WBA Walgreens Boots Alliance - 01/13/21
- Walgreens expands financial services in pact with Synchrony, Mastercard
- 01/12/21
- Walgreens Boots Alliance makes majority investment in iA
- 01/06/21
- Walgreens Boots Alliance accelerates VillageMD investment
- 01/06/21
- Walgreens expects to complete admin. of vaccine first doses in SNF by Jan. 25
- 01/19/21
- MoneyGram slides after Western Union announces pact with Walmart
- 01/19/21
- Western Union jumps 7% to $23.45 after money transfer pact with Walmart
- 01/19/21
- Walmart, Western Union partner to offer Western Union money transfers at Walmart
- 01/15/21
- Walmart U.S. eCommerce CEO Marc Lore to retire
- 12/21/20 Gabelli
- Teva named 'Best Idea for 2021' at Gabelli
- 11/27/20 H.C. Wainwright
- Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
- 11/24/20 Oppenheimer
- Teva initiated with a Perform at Oppenheimer
- 11/23/20 Citi
- Citi recommends pair trade of overweight Endo, underweight Teva
- 01/15/21 B. Riley Securities
- Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
- 01/14/21 Morgan Stanley
- 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
- 01/14/21 Oppenheimer
- Essa Pharma price target raised to $20 from $9 at Oppenheimer
- 12/29/20 Piper Sandler
- Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
- 12/24/20 Morgan Stanley
- Morgan Stanley sees greater FY22 COVID vaccine opportunity at McKesson
- 11/18/20 Jefferies
- Drug distributors' pullback on Amazon news an overreaction, says Jefferies
- 11/18/20 Goldman Sachs
- McKesson upgraded to Conviction Buy from Buy at Goldman Sachs
- 11/17/20 Goldman Sachs
- Goldman says Amazon news likely to pressure entire pharmacy supply chain
- 07:38 Today Argus
- AmerisourceBergen price target raised to $140 from $120 at Argus
- 01/07/21 Deutsche Bank
- AmerisourceBergen price target raised to $115 from $111 at Deutsche Bank
- 01/06/21 BofA
- AmerisourceBergen upgraded to Neutral from Underperform at BofA
- 11/18/20 Jefferies
- Drug distributors' pullback on Amazon news an overreaction, says Jefferies
- 01/08/21 Wolfe Research
- Cardinal Health upgraded to Peer Perform from Underperform at Wolfe Research
- 11/18/20 Jefferies
- Drug distributors' pullback on Amazon news an overreaction, says Jefferies
- 11/17/20 Goldman Sachs
- Goldman says Amazon news likely to pressure entire pharmacy supply chain
- 11/13/20 Mizuho
- Cardinal Health price target raised to $59 from $56 at Mizuho
- 01/19/21 JPMorgan
- Teladoc remains top 2021 healthcare technology pick at JPMorgan
- 01/08/21
- Fly Intel: Top five analyst upgrades
- 01/08/21 Jefferies
- CVS Health upgraded to Buy on COVID-19 vaccination upside at Jefferies
- 01/08/21 Jefferies
- CVS Health upgraded to Buy from Hold at Jefferies
WBA Walgreens Boots Alliance - 01/15/21 Baird
- Walgreens Boots Alliance price target raised to $64 from $55 at Baird
- 01/11/21
- Fly Intel: Top five analyst upgrades
- 01/11/21 Baird
- Baird upgrades Walgreens Boots Alliance following Q1 results
- 01/11/21 Guggenheim
- Walgreens Boots Alliance upgraded to Buy from Neutral at Guggenheim
- 01/20/21 Cleveland Research
- Walmart U.S. sales, share appear to be improving, says Cleveland Research
- 01/19/21 DA Davidson
- DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially
- 12/21/20
- Fly Intel: Top five analyst upgrades
- 12/21/20 RBC Capital
- Walmart upgraded to Outperform from Sector Perform at RBC Capital
- 11/05/20
- Teva sees FY20 EPS $2.40-$2.55, consensus $2.51
- 11/05/20
- Teva reports Q3 EPS 58c, consensus 58c
- 08/05/20
- Teva reports Q2 EPS 55c, consensus 53c
- 08/04/20
- Notable companies reporting before tomorrow's open
- 10/13/20
- Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021
- 10/13/20
- Johnson & Johnson sees Q4 sales 'around' 2019 levels, consensus $21.52B
- 10/13/20
- Johnson & Johnson raises FY20 adj. EPS view to $7.95-$8.05 from $7.75-$7.95
- 10/13/20
- Johnson & Johnson reports Q3 adj. EPS $2.20, consensus $1.98
- 11/03/20
- McKesson raises FY21 adj. EPS view to $16.00-$16.50 from $14.70-$15.50
- 11/03/20
- McKesson reports Q2 adj. EPS $4.80, consensus $3.87
- 11/02/20
- Notable companies reporting before tomorrow's open
- 11/02/20
- Notable companies reporting before tomorrow's open
- 01/06/21
- AmerisourceBergen raises FY21 EPS view to $8.25-$8.50, consensus $8.41
- 11/05/20
- AmerisourceBergen sees FY21 adjusted EPS $8.20-$8.45, consensus $8.42
- 11/05/20
- AmerisourceBergen reports Q4 adjusted EPS $1.89, consensus $1.85
- 11/04/20
- Notable companies reporting before tomorrow's open
- 11/05/20
- Cardinal Health raises FY21 EPS view to $5.65-$5.95 from $5.25-$5.65
- 11/05/20
- Cardinal Health reports Q1 EPS $1.51, consensus $1.13
- 11/04/20
- Notable companies reporting before tomorrow's open
- 11/04/20
- Notable companies reporting before tomorrow's open
- 11/06/20
- CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27
- 11/06/20
- CVS Health reports Q3 adj. EPS $1.66, consensus $1.33
- 11/05/20
- Notable companies reporting before tomorrow's open
- 11/05/20
- Notable companies reporting before tomorrow's open
WBA Walgreens Boots Alliance - 01/07/21
- Walgreens Boots Alliance backs FY21 adjusted EPS view up low single digits
- 01/07/21
- Walgreens Boots Alliance reports Q1 adjusted EPS $1.22, consensus $1.03
- 01/06/21
- Notable companies reporting before tomorrow's open
- 01/06/21
- Notable companies reporting before tomorrow's open
- 11/17/20
- Walmart reports Q3 adjusted EPS $1.34, consensus $1.18
- 11/16/20
- Notable companies reporting before tomorrow's open
- 11/16/20
- Notable companies reporting before tomorrow's open
- 08/18/20
- Walmart reports Q2 adjusted EPS $1.56, consensus $1.25
- 11/13/20
- Teva facing EU antitrust investigation over Copaxone sales, Bloomberg reports
- 10/21/20
- Purdue Pharma to plead guilty in $8B-plus deal, AP reports
- 10/02/20
- GlaxoSmithKline verdict of $235M against Teva revived on appeal, Bloomberg says
- 08/25/20
- Teva alleged to have overcharged U.S. consumers at least $350M, Bloomberg says
- 01/13/21
- Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says
- 01/13/21
- J&J chief science officer sees possible vaccine approval by March, Reuters says
- 01/13/21
- J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says
- 01/13/21
- EU lawmaker says J&J likely to submit vaccine approval in Feb., Reuters reports
- 01/20/21
- McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says
- 11/05/20
- Distributors and J&J closing in on $26B opioid settlement deal, NY Times says
- 09/24/20
- U.S. appeals court rejects novel opioid settlement framework, Reuters says
- 08/18/20
- States seeking $26.4B from pharma companies in opioid litigation, WSJ reports
- 11/05/20
- Distributors and J&J closing in on $26B opioid settlement deal, NY Times says
- 09/24/20
- U.S. appeals court rejects novel opioid settlement framework, Reuters says
- 08/18/20
- States seeking $26.4B from pharma companies in opioid litigation, WSJ reports
- 11/05/20
- Distributors and J&J closing in on $26B opioid settlement deal, NY Times says
- 09/24/20
- U.S. appeals court rejects novel opioid settlement framework, Reuters says
- 08/18/20
- States seeking $26.4B from pharma companies in opioid litigation, WSJ reports
- 01/02/21
- Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says
- 12/20/20
- CDC panel says frontline workers, people over 74 should be next, NYTimes reports
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 11/10/20
- Supreme Court appears unlikely to topple ACA, USA Today says
WBA Walgreens Boots Alliance - 12/20/20
- CDC panel says frontline workers, people over 74 should be next, NYTimes reports
- 11/01/20
- CVS, Walgreens among pharmacies set to give COVID vaccines, Bloomberg says
- 10/23/20
- HHS says thousands of facilities opt into CVS, Walgreens vaccine deal, CNBC says
- 10/16/20
- White House in vaccine administration deal with CVS, Walgreens, Politico reports
- 01/20/21
- Watchdog challenges Walmart's 'Made in USA' claims, NY Post reports
- 01/12/21
- Walmart, Disney halt donations to lawmakers against Biden win, Bloomberg says
- 01/12/21
- Walmart building new health venture, Business Insider reports
- 01/09/21
- Walmart stock could benefit as ESG investors add to funds, Barron's says
- 11/19/20
- Fly Intel: Wall Street's top stories for Thursday
- 11/19/20
- Fly Intel: Wall Street's top stories at midday
- 11/18/20
- Fly Intel: After-Hours Movers
- 08/26/20
- Fly Intel: Pre-market Movers
- 01/14/21
- Fly Intel: Wall Street's top stories for Thursday
- 01/14/21
- Fly Intel: Wall Street's top stories at midday
- 01/13/21
- Fly Intel: Wall Street's top stories for Wednesday
- 12/29/20
- Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades
- 11/24/20
- Fly Intel: Wall Street's top stories at midday
- 11/17/20
- Fly Intel: Wall Street's top stories for Tuesday
- 11/17/20
- Fly Intel: Wall Street's top stories at midday
- 11/17/20
- Pharmacy owners, suppliers slide after Amazon launches new offerings
- 01/06/21
- Fly Intel: Wall Street's top stories for Wednesday
- 01/06/21
- Fly Intel: Wall Street's top stories at midday
- 01/06/21
- Fly Intel: Pre-market Movers
- 11/17/20
- Fly Intel: Wall Street's top stories for Tuesday
- 11/17/20
- Fly Intel: Wall Street's top stories for Tuesday
- 11/17/20
- Fly Intel: Wall Street's top stories at midday
- 11/17/20
- Pharmacy owners, suppliers slide after Amazon launches new offerings
- 11/05/20
- Fly Intel: Pre-market Movers
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 11/17/20
- Fly Intel: Wall Street's top stories at midday
- 11/17/20
- Pharmacy owners, suppliers slide after Amazon launches new offerings
- 11/17/20
- Fly Intel: Pre-market Movers
WBA Walgreens Boots Alliance - 01/11/21
- Zillow, Walgreens upgrades among today's top calls on Wall Street
- 01/07/21
- Fly Intel: Wall Street's top stories for Thursday
- 01/07/21
- Fly Intel: Wall Street's top stories at midday
- 01/07/21
- Fly Intel: Pre-market Movers
- 01/12/21
- Fly Intel: Wall Street's top stories for Tuesday
- 01/12/21
- Fly Intel: Wall Street's top stories at midday
- 01/11/21
- Fly Intel: After-Hours Movers
- 12/22/20
- Fly Intel: Wall Street's top stories for Tuesday
- 01/19/21
- Teva call volume above normal and directionally bullish
- 01/06/21
- Notable open interest changes for January 6th
- 01/04/21
- Teva call volume above normal and directionally bullish
- 12/23/20
- Teva put volume heavy and directionally bearish
- 12/01/20
- Johnson & Johnson call volume above normal and directionally bullish
- 10/13/20
- Unusually active option classes on open October 13th
- 09/23/20
- Unusually active option classes on open September 23rd
- 08/24/20
- Unusually active option classes on open August 24th
- 11/03/20
- Early notable gainers among liquid option names on November 3rd
- 08/03/20
- Early notable gainers among liquid option names on August 3rd
- 01/06/21
- Early notable gainers among liquid option names on January 6th
- 10/15/20
- Early notable gainers among liquid option names on October 15th
- 11/05/20
- Early notable gainers among liquid option names on November 5th
- 09/24/20
- Largest borrow rate increases among liquid names
- 01/11/21
- CVS Health call volume above normal and directionally bullish
- 11/17/20
- Unusually active option classes on open November 17th
- 11/10/20
- CVS Health call volume above normal and directionally bullish
- 11/06/20
- Early notable gainers among liquid option names on November 6th
WBA Walgreens Boots Alliance - 01/11/21
- Early notable gainers among liquid option names on January 11th
- 12/31/20
- Walgreen Boots call volume above normal and directionally bullish
- 12/07/20
- Unusually active option classes on open December 7th
- 12/04/20
- Unusually active option classes on open December 4th
- 11/17/20
- Unusually active option classes on open November 17th
- 09/02/20
- Notable open interest changes for September 2nd
- 09/02/20
- Wal-Mart call buyer realizes 124% same-day gains
- 09/01/20
- Early notable gainers among liquid option names on September 1st
|